Epigral Ltd's stock rose after the release of their Q3FY25 results. The company's revenue grew 36.84 percent year-on-year to ₹645.24 crore from ₹471.52 crore. Net profit of the company surged 109.98 percent to ₹103.63 crore from ₹49.31 crore in the same quarter a year ago.